Are you Dr. Anderson?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 49 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3851 Piper St
Ste U340
Anchorage, AK 99508Phone+1 907-562-0321Fax+1 907-562-2683
Summary
- Dr. Jeanne Anderson, MD is an oncologist in Anchorage, Alaska. She is currently licensed to practice medicine in Alaska, Texas, and Washington. She is affiliated with Providence Alaska Medical Center and Alaska Regional Hospital.
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 1991 - 1994- University of WashingtonResidency, Internal Medicine, 1989 - 1991
Stanford Health Care-Sponsored Stanford UniversityInternship, Internal Medicine, 1988 - 1989
Stanford University School of MedicineClass of 1988
Certifications & Licensure
AK State Medical License 2001 - 2024
WA State Medical License 1990 - 2003
TX State Medical License 1998 - 2001
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2013
Clinical Trials
- S9920 Busulfan Compared With Cyclophosphamide in Patients Undergoing Total-Body Irradiation Plus Peripheral Stem Cell Transplantation for Advanced Myelodysplastic Syndrome or Related Acute Myeloid Leukemia Start of enrollment: 2000 Feb 01
- Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Myelofibrosis Start of enrollment: 2000 May 01
- Nab-Paclitaxel and Bevacizumab Followed By Bevacizumab and Erlotinib in Metastatic Breast Cancer Start of enrollment: 2008 Apr 23
- Join now to see all
Publications & Presentations
PubMed
- 1007 citationsAge and acute myeloid leukemiaFrederick R. Appelbaum, Holly Gundacker, David R. Head, Marilyn L. Slovak, Cheryl L. Willman
Blood. 2006-05-01 - 24 citationsCombined Targeted Therapies for First-line Treatment of Metastatic Triple Negative Breast Cancer-A Phase II Trial of Weekly Nab-Paclitaxel and Bevacizumab Followed by ...Lynn Symonds, Hannah M. Linden, Vijayakrishna K. Gadi, Larissa A. Korde, Eve T. Rodler
Clinical Breast Cancer. 2019-04-01 - 11 citationsIsozyme patterns in erythrocytes from human fetuses.S H Chen, Jeanne E. Anderson, Eloise R. Giblett, George Stamatoyannopoulos
American Journal of Hematology. 1977-01-01
